WHO INN approves ‘Usnoflast’ as recommended name for ZYIL1 from Zydus EP News Bureau Apr 2, 2024 Usnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus. Studies have demonstrated that ZYIL1 is…
